Mynaric AG has a consensus price target of $4 based on the ratings of 2 analysts. The high is $4 issued by Credit Suisse on January 12, 2023. The low is $4 issued by Credit Suisse on January 12, 2023. The 3 most-recent analyst ratings were released by Credit Suisse on January 12, 2023, November 2, 2022, and October 12, 2022, respectively. With an average price target of $7.67 between Credit Suisse, there's an implied 439.91% upside for Mynaric AG from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Mynaric (NASDAQ:MYNA) was reported by Credit Suisse on January 12, 2023. The analyst firm set a price target for $4.00 expecting MYNA to rise to within 12 months (a possible 191.97% upside). 0 analyst firms have reported ratings in the last year.
The latest analyst rating for Mynaric (NASDAQ:MYNA) was provided by Credit Suisse, and Mynaric downgraded their neutral rating.
There is no last upgrade for Mynaric
The last downgrade for Mynaric AG happened on January 12, 2023 when Credit Suisse changed their price target from $9 to $4 for Mynaric AG.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Mynaric, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Mynaric was filed on January 12, 2023 so you should expect the next rating to be made available sometime around January 12, 2024.
While ratings are subjective and will change, the latest Mynaric (MYNA) rating was a downgraded with a price target of $9.00 to $4.00. The current price Mynaric (MYNA) is trading at is $1.37, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.